Pacira Pharmaceuticals (PCRX) PT Raised to $72 at BMO Capital
Tweet
Share
E-mailGet Alerts PCRX Hot Sheet
Price: $67.95 -0.44%
Rating Summary:
14 Buy, 13 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 18 | New: 47
Rating Summary:
14 Buy, 13 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 18 | New: 47
Trade Now!
Join SI Premium – FREE
BMO Capital analyst Gary Nachman raised the price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $72.00 (from $65.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- UPDATE: Berenberg Starts Pacira Pharmaceuticals (PCRX) at Buy
- The Restaurant Group (RTN:LN) PT Raised to GBP1.70 at Jefferies
- AGC Inc (5201:JP) (ASGLY) PT Raised to JPY6,120 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
